The Online Investor



Pacira BioSciences Inc (PCRX)

Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and iovera°®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.

PCRX SEC Filing Email Alerts Service
Company Name: 
Pacira BioSciences Inc
Website: 
www.pacira.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding PCRX: 
53
Total Market Value Held by ETFs: 
$331.53M
Total Market Capitalization: 
$1.33B
% of Market Cap. Held by ETFs: 
25.00%
Quotes delayed 20 minutes

Email EnvelopeFree PCRX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (3.70 out of 4)
68th percentile
(ranked higher than approx. 68% of all stocks covered)

Analysts' Target Price:
PCRX Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Pacira BioSciences Inc (PCRX) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.